Shaping the Future: The Role of AI Governance in Medical Device Manufacturing
The integration of artificial intelligence (AI) into medical technologies is reshaping the landscape for medical device manufacturers. In addition to regulatory approval, demonstrating cybersecurity and responsible AI governance is becoming crucial in the procurement process. DQS, a global auditing and certification services provider, highlights the evolving customer expectations that are outpacing regulations, emphasizing the need for manufacturers to strengthen AI governance to meet market demands.
Dr. Yuan Li, Director of Medical Business at DQS, emphasizes the shift towards procurement approval alongside regulatory approval for medical device manufacturers. Healthcare organizations are increasingly seeking assurance that AI-enabled technologies are secure, reliable, and responsibly governed before being deployed for patient care. Cybersecurity has become a fundamental requirement in the healthcare supply chain, with certifications like ISO 27001 playing a key role in vendor evaluation during procurement.
As AI becomes more prevalent in medical devices, manufacturers are facing inquiries from healthcare organizations about how they govern AI models in addition to cybersecurity measures. The focus is expanding to include issues such as model oversight, bias, transparency, human accountability, and lifecycle management. ISO/IEC 42001 provides a framework for establishing and improving a management system to govern AI responsibly, addressing the unique risks introduced by AI technologies.
While ISO 42001 is not currently mandatory for most medical device manufacturers, DQS anticipates that market expectations will drive adoption ahead of regulatory requirements. Recent cyber incidents affecting medical technology organizations underscore the importance of viewing cybersecurity and AI governance as essential business priorities rather than mere compliance exercises. Companies that proactively prepare for evolving customer expectations will be better positioned in the competitive landscape.
As the adoption of AI accelerates in healthcare, DQS advises manufacturers to assess AI governance alongside their existing quality, cybersecurity, and risk management systems to stay competitive in the evolving market. By integrating responsible AI governance practices, manufacturers can enhance their credibility and meet the increasing demands of healthcare organizations and patients.